MnA round-up: AAA bags Atreus; Pulmonx acquires Aeris
This article was originally published in Clinica
Executive Summary
Medtech M&A activity shows no sign of slowing down in the New Year, with two more deals. French nuclear imaging firm Advanced Accelerator Applications (AAA) has bought the remaining 49.9% stake in Canada’s Atreus Pharmaceuticals; while Pulmonx, a specialist in minimally-invasive treatments for pulmonary disorders, has acquired the assets of Aeris Therapeutics, including its AeriSeal foam-based lung sealant system for the treatment of emphysema.